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Abstract
AIM: To determine the features of Enterococcus  that 
contribute to the development and maintenance of the 
inflammatory process in patients with inflammatory 
bowel disease (IBD). 
METHODS: Multiplex polymerase chain reaction (PCR) 
was applied to assess the presence of genes that en-
code virulence factors [surface aggregating protein 
(asa1), gelatinase (gelE ), cytolysin (cylA), extracellular 
surface protein (esp ) and hyaluronidase (hyl )] in the 
genomic DNA of 28 strains of Enterococcus  isolated 
from the intestinal tissues of children with IBD (n  = 
16) and of children without IBD (controls; n  = 12). Ad-
ditionally, strains with confirmed presence of the gelE  
gene were tested by PCR for the presence of quorum 
sensing genes (fsrA , fsrB , fsrC) that control the gelati-
nase production. Gelatinase activity was tested on agar 
plates containing 1.6% gelatin. We also analysed the 
ability of Enterococcus  strains to release and decom-
pose hydrogen peroxide (using Analytical Merckoquant 
peroxide test strips) and tested their ability to adhere 
to Caco-2 human gut epithelium cells and form biofilms 
in vitro .
RESULTS: A comparison of the genomes of Enterococ-
cus  strains isolated from the inflamed mucosa of pa-
tients with IBD with those of the control group showed 
statistically significant differences in the frequency of 
the asa1  gene and the gelE  gene. Furthermore, the cu-
mulative occurrence of different virulence genes in the 
genome of a single strain of Enterococcus  isolated from 
the IBD patient group is greater than in a strain from 
the control group, although no significant difference 
was found. Statistically significant differences in the 
decomposition of hydrogen peroxide and adherence to 
the Caco-2 epithelial cell line between the strains from 
the patient group and control group were demonstrat-
ed. The results also showed that profuse biofilm pro-
duction was more frequent among Enterococcus  strains 
isolated from children with IBD than in control strains.
CONCLUSION: Enterococcus  strains that adhere 
strongly to the intestinal epithelium, form biofilms and 
possess antioxidant defence mechanisms seem to have 
the greatest influence on the inflammatory process. 
© 2013 Baishideng. All rights reserved.
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which features make Enterococcus  strains contributing 
to the development and maintenance of the inflam-
matory process in patients with inflammatory bowel 
disease. The outcome of this research may have an 
impact on better understanding of the pathomecha-
nisms of this disease, as its etiology is not fully known. 
The study results suggest that Enterococcus  strains 
which adhere strongly to the intestinal epithelium, form 
biofilm as well as possess the enzymatic mechanisms 
protecting them against the effects of reactive oxygen 
species, seem to have the highest chances to survive 
and influence the inflammatory process.
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INTRODUCTION
Inflammatory bowel disease (IBD) refers to two disease 
entities: ulcerative colitis (UC) and Crohn’s disease (CD). 
UC is a chronic inflammatory process of  the mucous 
membranes of  the rectum and colon. Inflammatory 
changes in the form of  recurrent surface ulcerations are 
located along the whole length of  the large intestine. The 
course of  UC course ranges from mild disease activity, 
lasting for years, to severe disease that can result in death 
after only a few weeks. CD is a chronic inflammatory 
process that can affect any part of  the alimentary system, 
from the oral cavity to the rectum. 
The aetiology of  IBD is not yet fully understood[1]. 
Based on numerous clinical observations and results 
of  extensive in vitro and in vivo experiments, it is cur-
rently thought that this disease develops as a result of  
the concurrence of  three factors: genetic predisposition, 
disorders of  the immune system and the influence of  the 
environmental factors. Among the environmental factors, 
changes in the composition of  the bacterial flora that col-
onise the human alimentary tract are considered to be of  
great influence[2]. Consequently, a great deal of  attention 
is currently devoted to the study of  the bacterial species 
that constitute the normal alimentary tract flora com-
pared to those found in the tract of  the IBD patients.
From 2004 to 2006, research on the qualitative and 
quantitative changes in the microflora of  the alimentary 
tracts of  a group of  children who had been diagnosed 
with CD or UC for the first time was performed in our 
department[3,4]. No single aetiological factor that could 
be responsible for the exacerbation of  the progressing 
inflammatory process was confirmed based on the ob-
tained results. 
However, the analysis of  the quantitative changes in 
the group of  children with CD identified a significant 
increase in the population of  cocci (including Streptococ-
cus and Enterococcus) and bacteria belonging to the genus 
Lactobacillus in the inflammatorily changed sites with a si-
multaneous decrease in the number of  strictly anaerobic 
bacteria, particularly those belonging to the genus Bifido-
bacterium. 
All of  the above-mentioned bacteria are important 
members of  the commensal flora of  the human colon. 
Therefore, we must consider the mechanisms by which 
these bacteria may contribute to the development and/or 
maintenance of  the inflammatory process in patients 
suffering from IBD. The virulence potential of  the ge-
nus Enterococcus has been established in many publica-
tions, and it is this genus contributes to infections such 
as peritonitis, bloodstream and urinary tract infections 
and endocarditis[5,6]. Their potential role in the patho-
mechanisms leading to IBD has also been highlighted by 
research utilising IL-10 gene knockout mice to show that 
Enterococcus faecalis (E. faecalis) can induce IBD[7]. 
Recent studies on the pathogenicity of  enterococci 
indicate that the genomes of  strains that are able to 
cause tissue damage and inflammation contain a patho-
genicity island that encodes aggregation substance (AS), 
gelatinase, extracellular surface proteins (Esp), cytolysin, 
hyaluronidase and other proteins[8,9]. Enterococci that ex-
press AS were found to resist phagocytosis significantly 
better than an isogenic AS-negative strain by inhibiting 
the respiratory burst of  macrophages[10]. Gelatinase, a 
protease produced by enterococci, is capable of  hydro-
lysing gelatin, collagen, casein, haemoglobin and other 
peptides[9]. The Esp enhance biofilm formation in E. 
faecalis[11]. Cytolysin produced by the enterococci is lethal 
for a broad range of  prokaryotic and eukaryotic cells[12]. 
Hyaluronidase is mainly a degradative enzyme that is as-
sociated with tissue damage[13].
Little attention has been devoted to the ability of  en-
terococci to release hydrogen peroxide into the extracel-
lular space[14]. Pursuant to the results obtained previously 
by our group, select members of  several genera, includ-
ing Streptococcus, Enterococcus and Lactobacillus, are, under 
aerobic conditions, able to produce amounts of  hydrogen 
peroxide comparable to those released by cells of  the 
immune system during the oxidative burst[15]. This ad-
ditional source of  hydrogen peroxide could help sustain, 
or even exacerbate, gut inflammation[16]. Notably, certain 
Enterococcus strains can defend themselves against the sur-
plus of  reactive oxygen species (ROS) by producing anti-
oxidative enzymes to increase their chances of  survival in 
unfavourable conditions[17]. 
Thus, the main objective of  this work was to com-
pare the occurrence of  genes encoding selected virulence 
factors [surface aggregating protein (asa1), gelatinase 
(gelE), cytolysin (cylA), extracellular surface protein (esp) 
and hyaluronidase (hyl)] in the genomes of  Enterococcus 
strains isolated from patients suffering from IBD with 
the occurrence of  these genes in the genomes of  strains 
derived from the control group subjects. Additionally, 
strains confirmed positive for the gelE gene were tested 
for the presence of  the quorum sensing genes fsrA-C 
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that regulate gelatinase production, and gelatinase activ-
ity was tested on agar plates containing 1.6% gelatin. The 
adherence of  the Enterococcus strains to Caco-2 epithelial 
cells and their ability to form biofilms were also tested. 
Furthermore, the ability of  strains isolated from inflamed 
or non-inflamed gut mucosa to release and decompose 
extracellular hydrogen peroxide was assessed.
MATERIALS AND METHODS
Bacterial strains
Enterococcus strains were isolated from colon biopsies of  
34 children who were diagnosed with IBD for the first 
time and 24 patients from the control group comprised 
of  children with functional bowel disorders that were 
hospitalised in the same hospital during the same period 
of  time. Neither the IBD patients nor the participants 
in the control group received antibiotics during the two 
weeks prior to the study. The diagnosis of  CD or UC was 
based on endoscopic, histopathological, immunological 
and radiological criteria[3,4]. The biopsies were taken from 
both groups of  patients during colonoscopy procedures 
carried out at the Clinic of  Paediatrics, Gastroenterol-
ogy and Nutrition of  the Polish-American Institute of  
Paediatrics of  the Jagiellonian University Medical Col-
lege in Cracow pursuant to the approval of  the Bioethi-
cal Committee (No. KBET/236/B/2002). The patients 
were prepared for the colonoscopy using routine washing 
procedures described by Gosiewski et al[4]. During the 
colonoscopy, the location and intensity of  the lesions 
was assessed, and tissue fragments were obtained for 
histopathological and microbiological examinations. The 
biopsy samples were transported to the microbiological 
laboratory in Schaedler broth (SAB, Difco, United States, 
+ 10% glycerol) at -20 ℃.
In the laboratory, the frozen samples were thawed, 
weighed and homogenised in 1 mL of  SAB and quan-
titatively analysed for the main cultivable bacterial con-
stituents of  the colon microflora using differential media 
in aerobic and anaerobic conditions[3,4]. These steps were 
performed aseptically in an anaerobic chamber (MACS 
- MG 500 Work Station, DW Scientific, Shipley, United 
Kingdom) in N2 (85%) + H2 (10%) + CO2 (5%) atmos-
phere. The homogenised samples were serially diluted 
with SAB and 100 μL aliquots plated on the following 
media: McConkey Agar (Oxoid, Basingstoke, United 
Kingdom) for Enterobacteriaceae, Columbia Blood Agar 
(Difco, Lawrence, Kansas, United States) with 5% sheep 
blood for streptococci, Enterococcosel agar (BBL, BD, 
Franklin Lakes, United States) for enterococci, MRS agar 
(Oxoid) for lactobacilli and other lactic acid bacteria, BL 
agar for bifidobacteria and Wilkins-Chalgren agar base 
(Difco) with supplements for Bacteroides. 
The morphology of  the grown colonies was analysed 
using a magnifying glass, and several colonies of  each 
morphological type were subcultured on appropriate 
aerobic and anaerobic media and subsequently Gram-
stained. After further incubation and culture purity 
checks, the phenotypic identification was conducted 
with the use of  commercial identification systems (API 
20E, API20A, APIStaph, APIStrep, bioMerieux, Marcy 
l’Etoile, France; BBL Crystal ID System, BD, Franklin 
Lakes, United States). The identification was confirmed 
by species-specific multiplex polymerase chain reaction 
(PCR) as described by Jackson et al[18].
The selected strains were preserved at -80 ℃ on glass 
beads in BBL Nutrient Broth with the addition of  15% 
glycerol. 
Multiplex PCR
To detect presence of  genes encoding selected virulence 
factors (asa1, gelE, cylA, esp, hyl) in the genomes of  the 
tested strains, multiplex PCR was applied according to 
the methods of  Vankerckhoven[19]. 
PCR 
To investigate the presence of  quorum sensing genes 
(fsrA, fsrB, fsrC) in the genomes of  all the strains positive 
for the gelE gene, PCR was applied pursuant to Qin et 
al[20]. 
The reference strain E. faecalis ATTC29212 containing 
the gene fsrC was used as the positive control. The nega-
tive control was a reference strain of  E. faecium (ATTC 
35667) that did not possess any of  the examined genes. 
The product sizes for fsrA, fsrB and fsrC were 484 bp, 
574 bp and 580 bp, respectively (BLAST). 
Detection of gelatinase activity
The production of  gelatinase in Enterococcus strains was 
detected by the method described by Steck et al[6]. Super-
natants from overnight cultures were spotted onto tryptic 
soy agar supplemented with 0.5 g/L L-cysteine and 1.6% 
Difco gelatine. The zone of  clearance was measured after 
24 h of  incubation. 
Adherence to human gut epithelium cells and evaluation 
of biofilm production
The ability of  Enterococcus strains to adhere to Caco-2 hu-
man gut epithelium cells (ATCC HTB-37) was assessed 
using an in vitro assay according to Górska-Frączek[21]. 
Caco-2 cells were cultured for 24 h in a 12-well flat bot-
tom tissue culture plate at a density of  1 × 106 cells/mL 
(Iwaki, Japan) in Eagle’s 1959 medium (MEM) with 
L-glutamine and NaHCO3 (IITD, Wrocław, Poland) 
containing 5% foetal calf  serum (Sigma-Aldrich Chemie, 
Germany) and antibiotics (penicillin 100 UI/mL, strep-
tomycin 100 UI/mL, neomycin 200 μg/mL) (Sigma 
Aldrich Chemie, Germany) and were washed twice with 
PBS. Overnight cultures of  bacteria were diluted with 
MRS+MEM to a concentration of  about 108 CFU/mL. 
The Caco-2 cells were inoculated with the bacterial cul-
tures. After incubating at 37 ℃ for 30 min, wells were 
washed twice with PBS to release unbound bacteria. 
Then, the cells were fixed with 3.7% formaldehyde for 1 
h, washed twice with PBS and stained with crystal violet 
stain (Merck, Germany). The degree of  adhesion was 
evaluated using a semiquantitative scoring system ranging 
from (-) to (+++). The adherent Enterococcus cells were 
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strips (Merck, NJ, United States). The resulting amount 
of  H2O2 was converted from mg/L into mmol/L. Then, 
the number of  bacterial cells in each culture was deter-
mined using the viable count method. These levels were 
comparable for all strains and equalled approximately 8 × 
106 CFU/mL. The negative control was sterile TSB con-
taining 2 mmol/L H2O2. 
Statistical analysis
The statistical analysis was focused on comparison of  
probabilities of  the analyzed genes presence between the 
group of  the bacteria isolated from IBD children and this 
from control group. Such comparison was done using 
frequency χ 2 test. If  the given frequencies didn’t fulfill the 
assumption of  the test it’s less strong equivalents: likeli-
hood ratio of  Fisher’s exact test were used. The value P 
< 0.05 was regarded as the threshold for statistical signifi-
cance. All calculations were performed using JMP 7.0.2 
(SAS, United States) software package.
RESULTS
In total, 48 strains belonging to the genus Enterococcus 
were isolated. Of  these, 34 strains originated from chil-
dren diagnosed with IBD, including 21 from children di-
agnosed with CD and 13 from children with UC. In this 
group, 16 (47%) strains belonged to E. faecalis, 10 (29%) 
to E. avium and 8 (24%) to E. faecium. In the control 
group, 5 (36%) out of  14 strains were identified as E. fae-
calis, 4 (29%) as E. avium, 3 (21%) as E. faecium and 2 (14%) 
as E. durans (Table 1). 
For further studies, 28 Enterococcus strains were ran-
domly selected, including 16 strains from patients with 
IBD (n = 9 CD, n = 7 UC) and 12 strains from the con-
trol group (Tables 2, 3 and 4). Molecular typing of  all En-
terococcus isolates using PFGE procedure (not described 
here) was performed before selection to eliminate redun-
dant pulsotypes. No clustering within individual species 
or across the entire set of  strains was noted. 
While identifying genes coding for selected virulence 
factors (asa1, gelE, cylA, esp, hyl) in the genomes of  the 
Enterococcus strains isolated from the inflamed mucosa of  
IBD patients and from control group patients, statistically 
significant differences in the frequencies of  the asa1 gene, 
which encodes the surface aggregating proteins, and the 
gelE gene (P = 0.0091), which encodes the gelatinase that 
is responsible for decomposing collagen and elastin, were 
confirmed (Tables 2 and 3; Figures 1 and 2). 
The cylA gene, which encodes cytolysin, was detected 
in 2 strains of  E. faecalis and 1 strain of  Enterococcus fae-
cium isolated from the inflamed sites. This gene was not 
detected in the control strains. The obtained results were 
at the limit of  statistical significance (P = 0.0569). The 
esp gene encoding the extracellular surface protein was 
present in 11 strains isolated from patients with IBD 
and in 5 strains isolated from the control group. None 
of  the 28 strains examined, including strains from both 
research groups, contained the hyl gene that encodes hy-
counted in 20 randomly selected microscopic fields, as we 
have previously described[22]. 
Fifteen strains of enterococci collected from children 
with IBD and 10 strains from the control children were 
examined for biofilm formation in sterile plastic 96-well 
plates with an adherent surface (Greiner Bio-One, United 
States). Bacterial cells were grown in 10 mL of  trypticase 
soy broth (TSB, Difco) at 37 ℃ for 24 h in aerobic con-
ditions. The culture was then centrifuged (2000 r/min; 
10 min) and washed with 10 mL of  saline. A suspension 
of  each strain (1 × 105 CFU/mL) was prepared by serial 
dilution of  bacteria in saline using MacFarland’s scale, 
and then 20 μL of  the prepared suspension was added 
to a well followed by 180 μL of  sterile TSB. The final 
concentration of  bacteria was 1 × 104 CFU/mL. The 
plates were centrifuged for 10 min at 2000 r/min to sedi-
ment the bacteria onto the bottom of  each well and were 
then incubated for 48 h (37 ℃, aerobic conditions). The 
biofilm quantity (total mass of  bacterial polysaccharides) 
was measured using Congo red dye according to a modi-
fied procedure described by Reuter et al[23]. Briefly, at two 
different time points (0 and 48 h), the plates were centri-
fuged, the culture medium was gently removed from the 
wells and 200 μL of  0.1% Congo red solution was imme-
diately added. The plates were left at room temperature 
for 30 min and then washed twice with buffered saline 
to remove unbound dye. The absorbance was measured 
at a wavelength of  492 nm using a spectrophotometer 
(Awareness Technology, Inc.). All measurements were 
performed in triplicate, and the mean values ± SD were 
calculated. The degree of  biofilm production by the 
tested cocci was arbitrarily categorised as either highly 
positive (A492 ≥ 0.81) or weakly positive (A492 ≤ 0.8). 
Measurement of hydrogen peroxide production 
Analytical Merckoquant peroxide test strips (Merck, NJ, 
United States) were used to measure H2O2 production by 
the tested strains on a detection scale between 0 and 100 
mg/L. The tested bacteria were suspended in 2 mL of  
TSB broth (TSB) (Difco, Kansas, United States) and cul-
tured at 37 ℃ in aerobic conditions. The measurements 
of  H2O2 were performed after 4 and 24 h according to 
the procedure provided by the manufacturer. The mean 
density of  bacterial growth at 4 h was approximately 3 × 
106 CFU/mL and increased to 1 × 107 CFU/mL after 24 
h. Uninoculated TSB broth was used as a negative con-
trol. The amounts of  H2O2 are presented as mmol/L. 
Kinetics of the decomposition of hydrogen peroxide
The bacterial strains were cultured in 10 mL of  TSB for 
24 h at 37 ℃ in aerobic conditions. Their final density 
was approximately 0.5 on the McFarland scale. After 24 
h, chemically pure hydrogen peroxide (Sigma-Aldrich, 
United States) was added to each test culture at a final 
concentration of  2 mmol/L. The culture was incubated 
under the same conditions for 4 h, and the amount of  
hydrogen peroxide remaining in the test tube was then 
determined using Analytical Merckoquant peroxide test 
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aluronidase. No statistically significant differences were 
observed in the prevalence of  esp or hyl between the two 
patient groups (Figures 1 and 2). 
The cumulative occurrence of  different virulence 
genes in the genome of  a single strain of  Enterococcus iso-
lated from patients suffering from IBD was greater than 
that of  a strain isolated from the control group (mean of  
2.6 vs 2.0, respectively), but no significant difference was 
found. For instance, the strains E. faecalis 35A and E. fae-
cium 57A were isolated from patients with IBD and pos-
sessed as many as 4 virulence genes (cylA, esp, asa1 and 
gelE), but strains containing all four of  these genes were 
not observed in Enterococcus isolates from the control 
group. 
Further analysis was performed on strains in which 
the presence of  the gelE gene was confirmed (n = 19). 
Based on the results of  a PCR assay for the presence of  
the regulator genes fsrA-C, statistically significant differ-
ences between the two groups were noted for the occur-
rence of  fsrC. This gene was confirmed in 8 Enterococcus 
strains isolated from the study group, but it was detected 
in only 2 strains from the control group (P = 0.0195). 
Furthermore, the presence of  fsrA was confirmed in 3 
strains from the study group and in 1 Enterococcus strain 
from the control group. The fsrB gene was detected in 
the genome of  3 strains isolated from the IBD children 
and in 2 strains from the control group children. These 
results are shown in Table 2.
Enterococci containing the gene encoding gelatinase 
also underwent an in vitro test in which the activity of  
gelatinase on agar plates containing 1.6% gelatin was ex-
amined. Zones of  clearance were demonstrated only on 
plates inoculated with cultures of  strains that had all three 
regulator genes (fsrA, B and C): 2 Enterococcus strains from 
the studied group and 1 strain from the control group. No 
statistically significant differences were shown between 
these two groups. The results are shown in Table 2.
While testing the ability of  the enterococci to adhere 
to Caco-2 cells, statistically significant differences were 
demonstrated between the bacteria isolated from IBD 
children compared to controls. Ten of  the 24 enterococ-
cal strains from the IBD group strongly adhered to the 
Caco-2 cells (P = 0.0238). Only 1 strain from the control 
group adhered to the epithelial cell line used in the study. 
It is important to note that adherence was demonstrated 
by all strains having the asa1 gene, which encodes the sur-
face aggregating protein and allows for increased adher-
ence of  the bacteria to the host’s tissues. The results of  
this study are shown in Table 3. However, 6 strains from 
the control group and 1 strain from the study group with 
no confirmed presence of  asa1 gene also adhered to the 
cells. Therefore, there are other virulence factors that in-
crease bacterial adherence to host tissues.
All of  the tested Enterococcus strains were able to form 
biofilms structure within 48 h. However, the results 
demonstrated that profuse biofilm production was more 
frequent among strains isolated from children with IBD 
than in control strains. Among the enterococcal strains 
isolated from the studied group, 11 (73.3%) were abun-
dant biofilm producers (high positive; A492 ≥ 0.81), and 
4 (26.7%) were weak biofilm producers (low positive; 
A492 ≤ 0.8). Of  the 10 strains isolated from the control 
group, 2 (20%) were classified as abundant biofilm pro-
ducers and 8 (80%) were weak producers. The difference 
between the IBD and control groups was not statistically 
significant. The results of  the biofilm formation analysis 
are shown in Table 3 and Figure 3. 
While analysing the ability of  the strains to produce 









1 3A Enterococcus faecium CD/1
2 3B Enterococcus faecium
3 10A Enterococcus avium CD/2
4 12A/1 Enterococcus faecalis
5 12A/2 Enterococcus avium CD/3
6 12B Enterococcus faecium
7 25A Enterococcus faecium CD/4
8 25B Enterococcus avium
9 31B Enterococcus faecalis CD/5
10 42A/1 Enterococcus faecalis CD/6
11 42A/2 Enterococcus faecium
12 51A/1 Enterococcus faecalis CD/7
13 51A/2 Enterococcus avium
14 57A Enterococcus faecium CD/8
15 8A Enterococcus faecalis CD/9
16 8B/1 Enterococcus faecalis
17 8B/2 Enterococcus avium
18 19B Enterococcus faecium CD/10
19 22B Enterococcus faecalis CD/11
20 69A Enterococcus faecalis CD/12
21 79A Enterococcus faecalis CD/13
22 32B Enterococcus faecalis UC/1
23 35A Enterococcus faecalis UC/2
24 40A Enterococcus avium UC/3
25 40B Enterococcus avium
26 48A Enterococcus faecalis UC/4
27 58A Enterococcus faecalis UC/5
28 77A Enterococcus faecalis UC/6
29 33B Enterococcus avium UC/7
30 29B Enterococcus avium UC/8
31 34A/1 Enterococcus faecium UC/9
32 34A/2 Enterococcus avium
33 64B Enterococcus faecalis UC/10
34 65A Enterococcus faecalis UC/11
35 5B Enterococcus faecalis Control/1
36 7B Enterococcus faecium Control/2
37 15B/1 Enterococcus avium Control/3
38 15B/2 Enterococcus durans Control/4
39 16B/1 Enterococcus avium Control/5
40 16B/2 Enterococcus durans
41 27B/1 Enterococcus faecalis Control/6
42 27B/2 Enterococcus faecium
43 27B/3 Enterococcus avium
44 30B/1 Enterococcus faecium Control/7
45 30B/2 Enterococcus avium
46 46B Enterococcus faecalis Control/8 
47 55B Enterococcus faecalis Control/9 
48 66B Enterococcus faecalis Control/10
CD: Crohn’s disease; UC: Ulcerative colitis; PCR: Polymerase chain re-
action Species identification was conducted with the use of API Strep sys-
tem (bioMerieux) and multiplex polymerase chain reaction assays. 
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extracellular hydrogen peroxide, we observed that only E. 
faecium and E. avium species released hydrogen peroxide 
in amounts equal to or higher than 0.3 mmol/L. In total, 
5 of  the 16 Enterococcus strains isolated from patients with 
IBD and 3 of  the 12 strains isolated from the control 
group were able to produce extracellular hydrogen per-
oxide, but this difference was not statistically significant 
(Table 4).
On the other hand, significant differences in the abili-
ty of  the strains to decompose H2O2 were observed upon 
examination of  the 28 strains of  Enterococcus isolated 
from both groups. Two subgroups could be distinguished 
based on the amount of  decomposed hydrogen peroxide. 
The first group contained enterococci that decomposed 2 
mmol/L of  hydrogen peroxide to a level of  0-1 mmol/L 
in 4 h. The second group comprised strains that decom-
posed hydrogen peroxide to a level higher than 1 mmol/L. 
The difference in hydrogen peroxide decomposition 
ability was statistically significant between the Enterococcus 
strains isolated from patients with IBD and the strains 
isolated from control group patients (P = 0.04; Figure 4). 
DISCUSSION
Recently, an important role has been ascribed to the 
quantitative changes in the composition of  the intestinal 
flora during inflammation[15,24]. These changes are likely 
related to the alterations in structure and function of  the 
gut epithelium under inflammatory conditions that affect 
oxygenation, acidity and the functions of  many enzymes 
and may lead to the preferential selection of  microbial 
strains that are able to adapt to and/or interact with the 
inflamed epithelium.
In this work, Enterococcus strains were chosen for fur-
ther studies because of  their potential to be highly viru-
lent. We sought to detect the differences between the vir-
ulence potential of  the Enterococcus strains that colonised 
the intestines of  children with IBD and control strains 
isolated from children without signs of  gut inflammation. 
The virulence of  Enterococci can be linked to the pres-
ence of  specific virulence factors encoded by specific 
genes, including cytolytic toxin, extracellular surface 
protein and AS, serine protease, gelatinase, cell wall ad-
hesins, collagen-binding proteins and capsular polysac-
charides[19,25].
In the presented study, statistically significant dif-
ferences were demonstrated for the occurrence of  the 
asa1 gene in the population of  Enterococcus strains iso-
lated from gut biopsies taken from patients with IBD in 
comparison to those cultured from those of  the control 
+: Presence of gene and/or gelatinase activity; -: Lack of gene and/or gelatinase activity Denotes significant (P = 00195 vs control group) differences in the 
occurrence of the fsrC gene between the study group and the control group. 
Table 2  Presence of the gelE  gene, quorum sensing genes (fsrA , fsrB , fsrC) and gelatinase activity in tested Enterococcus  strains
Source Strains Detection of genes Gelatinase activity on 16% gelatin plates
gelE fsrA fsrB fsrC
Crohn's disease Enterococcus faecalis 12A/1 + - - + -
Enterococcus faecalis 31B + - + + -
Enterococcus faecalis 51A/1 + - - + -
Enterococcus faecium 3A + + + + +
Enterococcus faecium 57A + - - - -
Enterococcus faecium 19B + + - - -
Enterococcus avium 51A/2 - - - - -
Enterococcus avium 25B + - - + -
Enterococcus avium 10A + - - - -
Ulcerative colitis Enterococcus faecalis 35A + - - - -
Enterococcus faecalis 48A + - - + -
Enterococcus faecalis 77A + - - + -
Enterococcus faecalis 32B + + + + +
Enterococcus avium 40A + - - - -
Enterococcus avium 34A/2 - - - - -
Enterococcus avium 40B + - - - -
Control Enterococcus faecalis 5B + - - +
Enterococcus faecalis 27B/1 + + + + +
Enterococcus faecalis 46B + - + - -
Enterococcus faecalis 55B - - - - -
Enterococcus faecalis 66B - - - - -
Enterococcus faecium 27B/2 + - - - -
Enterococcus faecium 30B - - - - -
Enterococcus avium 15B/1 - - - - -
Enterococcus avium 16B/1 - - - - -
Enterococcus avium 27B/3 + - - - -
Enterococcus durans 15B/2 - - - - -
Enterococcus durans 16B/2 - - - - -
ATCC control Enterococcus faecalis 29212 + - - + -
Enterococcus faecium 35667 - - - - -
Golińska E et al . Virulence factors of Enterococcus  and IBD
3568 June 21, 2013|Volume 19|Issue 23|WJG|www.wjgnet.com
group without gut inflammation. The asa1 gene is re-
sponsible for bacterial aggregation on the surface of  the 
host tissues (particularly enterocytes, neutrophil granulo-
cytes and epithelial cells of  the urinary tract), and it also 
enables conjugation between bacteria due to increased 
hydrophobicity of  the cell wall surface[26]. Consequently, 
strains that possess the asa1 gene can develop large ag-
gregations of  bacterial cells during an infection and may 
simultaneously increase the bacterial population[27]. This 
property is likely to be important in the pathomechanism 
underlying IBD because during episodes of  diarrhoea, 
one of  the main symptoms of  IBD, the majority of  the 
alimentary tract flora is removed with the intestinal con-
tents. Enterococci that express the asa1 gene are able to 
strongly adhere to intestinal surfaces lacking a mucous 
layer and are able to form biofilms for protection against 
unfavourable environmental factors.
Furthermore, experiments using a rat model of  en-
docarditis have shown that enterococci equipped with 
the asa1 gene are better able to survive inside stimulated 
immune cells, indicating that they may possess enzymatic 
mechanisms that protect them against the influence of  
ROS secreted by macrophages during the respiratory 
burst[10]. 
The gelE gene was more frequently found in the ge-
nomes of  enterococci isolated from the group of  chil-
dren with IBD. However, the presence of  the gelE gene 
alone is not sufficient for the production of  gelatinase 
protein by bacteria. Therefore, we also detected the quo-
rum sensing genes that regulate gelatinase production. 
Gelatinase is a zinc-dependent metalloproteinase that is 
capable of  hydrolysing gelatin, collagen, casein, haemo-
globin and human endothelin[28]. Its activity is one of  
the main causes of  the pathological changes in the host’s 
body upon infection with E. faecalis[25]. It is therefore pos-
sible that colonisation of  the alimentary tract of  patients 
with IBD with Enterococcus strains possessing the gelE 
gene can weaken the tight junction protein connections 
between the epithelial cells lining the intestinal walls of  
the host, thus leading to the disruption of  the mucous 
barrier[6].
Cytolysin, encoded by the cylA gene, contributes to 
another pathomechanism of  IBD that causes the exces-
sive lysis of  erythrocytes, leading to the uncontrolled re-
lease of  large amounts of  haemoglobin and subsequently 
heme and iron ions that influence the populations of  
Enterobacteriaceae, which are able to acquire iron[29]. There-
fore, the increased number of  enterococci that are able to 
decompose haemoglobin may be related to increases in 
the E. coli population observed in patients with IBD[30].
Another Enterococcus virulence factor examined in this 
study was the esp gene, which encodes the extracellular 
Table 3  Presence of asa1  gene, degree of adhesion to human gut epithelium cells and biofilm production among Enterococcus  
strains
Source Strains asa1 Adherence Biofilm production (after 48 h) A 492 nm ± SD
Crohn's disease Enterococcus faecalis 12A/1 - +++ 0.995 ± 0.351
Enterococcus faecalis 31B - +++ 1.302 ± 0.585
Enterococcus faecalis 51A/1 - ++ 1.083 ± 0.413
Enterococcus faecium 3A - - 1.286 ± 0.088
Enterococcus faecium 57A + +++ 0.698 ± 0.066
Enterococcus faecium 19B + +++ 1.087 ± 0.368
Enterococcus avium 51A/2 - - 2.101 ± 0.424
Enterococcus avium 25B - - 2.474 ± 0.683
Enterococcus avium 10A - - 1.423 ± 0.284
Ulcerative colitis Enterococcus faecalis 35A + +++ 1.528 ± 0.326
Enterococcus faecalis 48A - +++ 0.767 ± 0.582
Enterococcus faecalis 77A - ++ 0.822 ± 0.196
Enterococcus faecalis 32B + ++ 0.557 ± 0.344
Enterococcus avium 40A - +++ 0.859 ± 0.152
Enterococcus avium 34A/2 - -
Enterococcus avium 40B - - 0.282 ± 0.078
Control Enterococcus faecalis 5B - 0.512 ± 0.065 
Enterococcus faecalis 27B/1 - - 0.934 ± 0.103
Enterococcus faecalis 46B - ++ 0.507 ± 0.095
Enterococcus faecalis 55B - - 0.408 ± 0.242
Enterococcus faecalis 66B - - 0.172 ± 0.031
Enterococcus faecium 27B/2 - 0.917 ± 0.269
Enterococcus faecium 30B - - 0.359 ± 0.087
Enterococcus avium 15B/1 - -
Enterococcus avium 16B/1 - - 0.305 ± 0.104
Enterococcus avium 27B/3 - - 0.657 ± 0.182
Enterococcus durans 15B/2 - -
Enterococcus durans 16B/2 - - 0.315 ± 0.246
ATCC control Enterococcus faecalis 29212 + +++ 0.877 ± 0.221
Enterococcus faecium 35667 - ++ 0.722 ± 0.371
Adhesion degree was assessed as +++ (strong adhesive abilities); ++ (average adhesive abilities) and - (lack of adhesive abilities). Biofilm formation was 
measured in triplicate at two time points (0 and 48 h). The differences between the time points were averaged, and the mean ± SD are shown. 
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surface protein (Esp). The esp gene was present in 11 
strains of  enterococci from the group of  children with 
the IBD and in 5 strains from the control group. This 
finding may indicate that enterococci found in biopsy 
samples from ulcerations were able to adhere to and 
colonise the intestinal tissues more easily because Esp 
promotes primary attachment and biofilm formation in E. 
faecalis, as proved demonstrated by Toledo-Arana et al[31]. 
It should be noted here that our studies on the select-
ed virulence factors were based only on the detection of  
the specified genes that encode these factors, and more 
information could be obtained from the direct detection 
of  these factors in bacteria using enterocytes in in vitro 
systems or in animal experiments because the expres-
sion of  the studied genes may be specifically altered in 
inflamed tissues[32].
In the alimentary tract of  patients suffering from 
IBD, there can be a local accumulation of  large amounts 
of  ROS released by stimulated phagocytic cells, such as 
macrophages and neutrophils, due to the progressing 
Table 4  Mean amounts of hydrogen peroxide (in mmol/L) produced in vitro  after 4 and 24 h by the tested strains
Source Strains H2O2 production (mmol/L) after 4 h H2O2 production (mmol/L) after 24 h
Crohn's disease Enterococcus faecalis 12A/1 0 0
Enterococcus faecalis 31B 0 0
Enterococcus faecalis 51A/1 0 0
Enterococcus faecium 3A 0 0
Enterococcus faecium 57A 0 0
Enterococcus faecium 19B 0    0.3
Enterococcus avium 51A/2 0    0.3
Enterococcus avium 25B 0    0.3
Enterococcus avium 10A    0.3 1
Ulcerative colitis Enterococcus faecalis 35A 0 0
Enterococcus faecalis 48A 0 0
Enterococcus faecalis 77A 0 0
Enterococcus faecalis 32B 0 0
Enterococcus avium 40A 0 0
Enterococcus avium 34A/2 0    0.3
Enterococcus avium 40B 0 0
Control Enterococcus faecalis 5B 0 0
Enterococcus faecalis 27B/1 0 0
Enterococcus faecalis 46B 0 0
Enterococcus faecalis 55B 0 0
Enterococcus faecalis 66B 0 0
Enterococcus faecium 27B/2 0    0.3
Enterococcus faecium 30B 0 0
Enterococcus avium 15B/1    0.3 1
Enterococcus avium 16B/1 0 0
Enterococcus avium 27B/3 0    0.3
Enterococcus durans 15B/2 0 0
Enterococcus durans 16B/2 0 0









































































Figure 1  Agarose gel electrophoresis of multiplex polymerase chain reaction amplification products from Enterococcus species isolates. The reference 
strain Enterococcus faecalis (E. faecalis) ATTC29212 (EF reference strain) possessing the genes cylA, asa1 and gelE constituted the positive control. The negative 
control was a reference strain of Enterococcus faecium (E. faecium) ATTC 35667 Efm reference strain that did not possess any of the examined genes. Product sizes 
were as follows, asa1: 375 bp; gelE: 213 bp; cylA: 688 bp; esp: 510 bp; hyl: 276 bp. EF: Tested strains of E. faecalis; Efm: Tested strains of E. faecium; M: Mass 
marker 100-1000 bp. 
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acute and subsequently chronic inflammatory process. 
Additionally, some species of  Lactobacillus, Streptococcus and 
Enterococcus that colonise the human intestinal tract are 
able to produce substantial amounts of  superoxide (O2-) 
and hydrogen peroxide (H2O2) that are comparable to 
those released by immune cells[33,34]. However, as has been 
shown by Al-Mushrif  and Jones, the oxygen concentra-
tion present in the specific ecological niche regulates the 
bacterial production of  hydrogen peroxide[35]. As we have 
previously demonstrated and discussed elsewhere (Strus 
et al[15]), the oxygen tension in inflamed tissues during the 
course of  IBD enables the propagation of  facultative 
aerobes such as Enterococcus spp. and the production of  
considerable amounts of  hydrogen peroxide and other 
metabolites. Selected Enterococcus strains belonging to the 
species E. avium and E. faecium isolated from patients with 
IBD and children from the control group were able to 
produce extracellular hydrogen peroxide in our studies. 
This result may indicate that the production of  hydrogen 
peroxide is due to certain Enterococcus species rather than 
the inflammatory conditions at the site of  their isolation. 
Bacteria belonging to the genera Streptococcus, Lactoba-
cillus and Enterococcus occur in increased numbers in the 
alimentary tracts patients with IBD and can produce sig-
nificant amounts of  H2O2 that can consequently limit the 
population of  anaerobic flora, stimulate the cells of  the 
immune system to release pro-inflammatory cytokines 
and stimulate the apoptosis of  intestinal epithelial cells 
deprived of  their protective mucous layer[36]. Denning 
et al[16] showed that hydrogen peroxide concentrations 
ranging from 0.5 up to 2 mmol/L were able to induce 
apoptosis in the cells of  the abdominal lining and intesti-
nal epithelium; similar amounts of  H2O2 were produced 
in vitro by the Enterococcus strains examined in this study. 
These observations support the studies by Kruidenier et 
al[37] and underline the importance of  oxidative stress in 
the pathogenesis of  IBD.
During the inflammatory process, the intestinal epi-
thelial cells are exposed to the effects of  ROS. If  this is a 
short-term process, no significant damage or disruption 
of  host cell function are observed due to the production 
of  enzymes that inactivate ROS, such as catalase and per-
oxidase, and DNA repair mechanisms. A significant risk 
for the intestinal epithelium occurs when ROS are gen-
erated at variable concentrations for a longer period of  
time. Then, not only can the host cells be damaged, but 
the qualitative and quantitative composition of  the spe-
cific bacterial species that comprise the commensal flora 
changes as well[35].
In this work, we showed that enterococci isolated 
from patients with IBD were able to decompose hydro-
gen peroxide considerably faster than those isolated from 
the control group. This may indicate that these strains 
survived the selective pressures of  the inflammatory 
process. It is likely that only bacterial species possessing 
a system capable of  enzymatic deactivation of  ROS were 
able to survive and subsequently increase their popula-








































Figure 2  Presence of virulence factors in Enterococcus strains. Significant 
differences in the occurrence of the asa1 gene (aP = 0.0258 vs control group) 
and the gelE gene (bP = 0.0091 vs control group) were detected between 
strains isolated from children with inflammatory bowel disease (IBD) and strains 
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Figure 3  Comparison of the ability of the tested Enterococcus strains to 
form biofilms. The biofilm-forming abilities were assessed after 48 h, and all 
tested strains were classified as either abundant biofilm producers (high posi-
tive strains) or weakly adherent isolates (low positive strains). IBD: Inflamma-
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Figure 4  Decomposition of hydrogen peroxide by the tested strains. 
Statistically significant differences (aP = 0.04 vs control group) in the decompo-
sition of H2O2 (to a level higher than 1 mmol/L) were detected between strains 
isolated from patients with inflammatory bowel disease and from participants in 
the control group. 
a
Golińska E et al . Virulence factors of Enterococcus  and IBD
3571 June 21, 2013|Volume 19|Issue 23|WJG|www.wjgnet.com
cells in patients with IBD. Until recently, bacteria belong-
ing to the genera Enterococcus, Lactobacillus and Pediococcus 
were regarded as catalase negative. However, it appears 
that these bacteria have a very efficient system of  hydro-
gen peroxide deactivation based on manganese-contain-
ing catalase or haeme-dependent catalase[38]. 
In this study, we present data that suggest that proc-
esses in the alimentary tract of  patients with IBD (most 
probably based on inflammatory background of  this dis-
ease) may lead to the selection of  certain bacterial species 
or strains from the constituents of  the commensal flora. 
Our observations have been supported by recent studies 
on microbiota from biopsies taken from patients with 
UC and controls performed by Fite et al[39], who detected 
statistically significant differences in the bacterial popula-
tions of  the UC mucosa and in the control group that 
varied over the study period. High clinical activity indices 
and sigmoidoscopy scores were associated with entero-
bacteria, desulfovibrios, Type E Clostridium perfringens 
and E. faecalis. We believe that in case of  Enterococcus, the 
strains that adhere strongly to the intestinal epithelium, 
build three-dimensional biofilm structures and possess 
enzymatic mechanisms to protect against the effects of  
ROS produced by the immune cells and other bacterial 
species have the highest chances of  survival. 
COMMENTS
Background
Inflammatory bowel disease (IBD) is a chronic inflammation of all or part of the 
digestive tract. The aetiology of IBD is not fully known, but much attention is 
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